Works matching AU Hasumi, Hisashi

Results: 58
    1
    2
    3

    Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 17, p. 4227, doi. 10.3390/cancers15174227
    By:
    • Kawahara, Takashi;
    • Hasizume, Akihito;
    • Uemura, Koichi;
    • Yamaguchi, Katsuya;
    • Ito, Hiroki;
    • Takeshima, Teppei;
    • Hasumi, Hisashi;
    • Teranishi, Jun-ichi;
    • Ousaka, Kimito;
    • Makiyama, Kazuhide;
    • Uemura, Hiroji
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Early assessment with <sup>18</sup>F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.

    Published in:
    2019
    By:
    • Tabei, Tadashi;
    • Nakaigawa, Noboru;
    • Kaneta, Tomohiro;
    • Ikeda, Ichiro;
    • Kondo, Keiichi;
    • Makiyama, Kazuhide;
    • Hasumi, Hisashi;
    • Hayashi, Narihiko;
    • Kawahara, Takashi;
    • Izumi, Koji;
    • Osaka, Kimito;
    • Muraoka, Kentaro;
    • Teranishi, Jun-Ichi;
    • Miyoshi, Yasuhide;
    • Yumura, Yasushi;
    • Uemura, Hiroji;
    • Kobayashi, Kazuki;
    • Inoue, Tomio;
    • Yao, Masahiro
    Publication type:
    journal article
    15

    Regulation of Mitochondrial Oxidative Metabolism by Tumor Suppressor FLCN.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 22, p. 1750, doi. 10.1093/jnci/djs418
    By:
    • Hasumi, Hisashi;
    • Baba, Masaya;
    • Hasumi, Yukiko;
    • Huang, Ying;
    • Oh, Hyoungbin;
    • Hughes, Robert M.;
    • Klein, Mara E.;
    • Takikita, Shoichi;
    • Nagashima, Kunio;
    • Schmidt, Laura S.;
    • Linehan, W. Marston
    Publication type:
    Article
    16

    Measurement of serum isoform [–2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2–10 ng/ml.

    Published in:
    Scandinavian Journal of Urology (Taylor & Francis Ltd), 2017, v. 51, n. 4, p. 251, doi. 10.1080/21681805.2017.1298155
    By:
    • Furuya, Kazuhiro;
    • Kawahara, Takashi;
    • Narahara, Masaki;
    • Tokita, Takashi;
    • Fukui, Sachi;
    • Imano, Masashi;
    • Mitome, Taku;
    • Ito, Yusuke;
    • Izumi, Koji;
    • Osaka, Kimito;
    • Yokomizo, Yumiko;
    • Hayashi, Narihiko;
    • Hasumi, Hisashi;
    • Nawata, Shintaro;
    • Kawano, Tsuyoshi;
    • Yao, Masahiro;
    • Uemura, Hiroji
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.

    Published in:
    Familial Cancer, 2021, v. 20, n. 1, p. 75, doi. 10.1007/s10689-020-00195-0
    By:
    • Iribe, Yasuhiro;
    • Furuya, Mitsuko;
    • Shibata, Yousuke;
    • Yasui, Masato;
    • Funahashi, Makoto;
    • Ota, Junichi;
    • Iwashita, Hiromichi;
    • Nagashima, Yoji;
    • Hasumi, Hisashi;
    • Hayashi, Narihiko;
    • Makiyama, Kazuhide;
    • Kondo, Keiichi;
    • Tanaka, Reiko;
    • Yao, Masahiro;
    • Nakaigawa, Noboru
    Publication type:
    Article
    26
    27
    28

    One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.

    Published in:
    2017
    By:
    • Ito, Hiroki;
    • Kondo, Keiichi;
    • Kawahara, Takashi;
    • Kaneta, Tomohiro;
    • Tateishi, Ukihide;
    • Ueno, Daiki;
    • Namura, Kazuhiro;
    • Kobayashi, Kazuki;
    • Miyoshi, Yasuhide;
    • Yumura, Yasushi;
    • Makiyama, Kazuhide;
    • Hayashi, Narihiko;
    • Hasumi, Hisashi;
    • Osaka, Kimito;
    • Yokomizo, Yumiko;
    • Teranishi, Jun-ichi;
    • Hattori, Yusuke;
    • Inoue, Tomio;
    • Uemura, Hiroji;
    • Yao, Masahiro
    Publication type:
    journal article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.

    Published in:
    2018
    By:
    • Kawahara, Takashi;
    • Ishiguro, Yukari;
    • Ohtake, Shinji;
    • Kato, Ikuma;
    • Ito, Yusuke;
    • Ito, Hiroki;
    • Makiyama, Kazuhide;
    • Kondo, Keiichi;
    • Miyoshi, Yasuhide;
    • Yumura, Yasushi;
    • Hayashi, Narihiko;
    • Hasumi, Hisashi;
    • Osaka, Kimito;
    • Muraoka, Kentaro;
    • Izumi, Koji;
    • Teranishi, Jun-ichi;
    • Uemura, Hiroji;
    • Yao, Masahiro;
    • Nakaigawa, Noboru
    Publication type:
    journal article
    39
    40
    41
    42

    HIF1α Plays a Crucial Role in the Development of TFE3–Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis.

    Published in:
    Genes to Cells, 2025, v. 30, n. 1, p. 1, doi. 10.1111/gtc.13195
    By:
    • Nishizawa, Hidekazu;
    • Funasaki, Shintaro;
    • Ma, Wenjuan;
    • Kubota, Yoshiaki;
    • Watanabe, Kazuhide;
    • Arima, Yuichiro;
    • Kuroda, Shoichiro;
    • Ito, Takaaki;
    • Furuya, Mitsuko;
    • Motoshima, Takanobu;
    • Nishiyama, Akira;
    • Mehanna, Sally;
    • Satou, Yorifumi;
    • Hasumi, Hisashi;
    • Jikuya, Ryosuke;
    • Makiyama, Kazuhide;
    • Tamura, Tomohiko;
    • Oike, Yuichi;
    • Tanaka, Yasuhito;
    • Suda, Toshio
    Publication type:
    Article
    43

    Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation.

    Published in:
    Journal of Bone & Mineral Research, 2018, v. 33, n. 10, p. 1785, doi. 10.1002/jbmr.3477
    By:
    • Baba, Masaya;
    • Endoh, Mitsuhiro;
    • Ma, Wenjuan;
    • Toyama, Hirofumi;
    • Hirayama, Akiyoshi;
    • Nishikawa, Keizo;
    • Takubo, Keiyo;
    • Hano, Hiroyuki;
    • Hasumi, Hisashi;
    • Umemoto, Terumasa;
    • Hashimoto, Michihiro;
    • Irie, Nobuko;
    • Esumi, Chiharu;
    • Kataoka, Miho;
    • Nakagata, Naomi;
    • Soga, Tomoyoshi;
    • Yao, Masahiro;
    • Kamba, Tomomi;
    • Minami, Takashi;
    • Ishii, Masaru
    Publication type:
    Article
    44
    45

    H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.

    Published in:
    Human Molecular Genetics, 2017, v. 26, n. 2, p. 354, doi. 10.1093/hmg/ddw392
    By:
    • Hisashi Hasumi;
    • Yukiko Hasumi;
    • Baba, Masaya;
    • Hafumi Nishi;
    • Mitsuko Furuya;
    • Vocke, Cathy D.;
    • Lang, Martin;
    • Irie, Nobuko;
    • Chiharu Esumi;
    • Merino, Maria J.;
    • Takashi Kawahara;
    • Yasuhiro Isono;
    • Kazuhide Makiyama;
    • Warner, Andrew C.;
    • Haines, Diana C.;
    • Ming-Hui Wei;
    • Zbar, Berton;
    • Hagenau, Herbert;
    • Feigenbaum, Lionel;
    • Keiichi Kondo
    Publication type:
    Article
    46
    47

    Blood and lymphatic systems are segregated by the FLCN tumor suppressor.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-20156-6
    By:
    • Tai-Nagara, Ikue;
    • Hasumi, Yukiko;
    • Kusumoto, Dai;
    • Hasumi, Hisashi;
    • Okabe, Keisuke;
    • Ando, Tomofumi;
    • Matsuzaki, Fumio;
    • Itoh, Fumiko;
    • Saya, Hideyuki;
    • Liu, Chang;
    • Li, Wenling;
    • Mukouyama, Yoh-suke;
    • Marston Linehan, W.;
    • Liu, Xinyi;
    • Hirashima, Masanori;
    • Suzuki, Yutaka;
    • Funasaki, Shintaro;
    • Satou, Yorifumi;
    • Furuya, Mitsuko;
    • Baba, Masaya
    Publication type:
    Article
    48
    49
    50